Your browser doesn't support javascript.
loading
Dual progestin therapy for fertility-sparing treatment of grade 2 endometrial adenocarcinoma.
Newtson, A M; Pakish, J B; Nick, A M; Westin, S N.
Afiliação
  • Newtson AM; University of Iowa Hospitals and Clinics, Department of Obstetrics and Gynecology, United States.
  • Pakish JB; The University of Texas MD Anderson Cancer Center, Department of Gynecologic Oncology and Reproductive Medicine, United States.
  • Nick AM; The University of Texas MD Anderson Cancer Center, Department of Gynecologic Oncology and Reproductive Medicine, United States.
  • Westin SN; The University of Texas MD Anderson Cancer Center, Department of Gynecologic Oncology and Reproductive Medicine, United States.
Gynecol Oncol Rep ; 21: 117-118, 2017 Aug.
Article em En | MEDLINE | ID: mdl-28831417
•A case of grade 2 endometrial adenocarcinoma in a young woman desiring fertility-sparing treatment•Successful conservative management of refractory endometrial adenocarcinoma with dual progestin therapy•A brief review of conservative management in endometrial adenocarcinoma.
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article